Anti-CD19-CAR-transduced-T-cells/LCAR-B38M-CAR-T-cell-therapyCytokine release syndrome: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1804卷 / 1期

关键词：

D O I：

10.1007/s40278-020-78462-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：33 / 33

相关论文

共 50 条

[1] Anti-CD19-CAR-transduced-T-cells/AntineoplasticsCytokine release syndrome following off label use of anti-CD19-CAR-transduced-T-cells and treatment failure: 7 case reports
Reactions Weekly, 2021, 1867 (1) : 35 - 35
[2] Anti-CD19-CAR-transduced-T-cells/pembrolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2020, 1802 (1) : 37 - 37
[3] Anti-CD19-CAR-transduced-T-cells/sintilimabLack of efficacy: 6 case reports
Reactions Weekly, 2023, 1984 (1) : 53 - 53
[4] Anti-cd19-car-transduced-t-cells/car-bcma-t-cellVarious toxicities: 7 case reports
Reactions Weekly, 2023, 1957 (1) : 39 - 39
[5] Anti-CD19-CAR-transduced-T-cells/antineoplasticsVarious toxicities: 2 case reports
Reactions Weekly, 2025, 2056 (1) : 49 - 49
[6] Anti-cd19-car-transduced-t-cells/ibrutinibLack of efficacy: 7 case reports
Reactions Weekly, 2022, 1889 (1) : 32 - 32
[7] Anti-CD19-CAR-transduced-T-cells/blinatumomab/inotuzumab ozogamicinCytokine release syndrome and CNS toxicity: 5 case reports
Reactions Weekly, 2020, 1792 (1) : 23 - 23
[8] Anti-cd19-car-transduced-t-cells/auto-3Cytokine release syndrome and hemophagocytic syndrome: case report
Reactions Weekly, 2020, 1828 (1) : 55 - 55
[9] Anti-CD19-CAR-transduced-t-cells/antineoplasticsIntrahepatic cholangiocarcinoma: case report
Reactions Weekly, 2020, 1800 (1) : 40 - 40
[10] Anti-CD19-CAR-transduced-T-cells/lenalidomideMultiple toxicities: case report
Reactions Weekly, 2021, 1870 (1) : 33 - 33

← 1 2 3 4 5 →